Links between Fer tyrosine kinase expression levels and prostate cell proliferation

Molecular and Cellular Endocrinology

Volumn 159, Issue 1-2, 2000, Pages 63-77

  Allard, Pierre ^a,c   Zoubeidi, Amina ^a,c   Nguyen, Linh T ^a,c   Tessier, Sylvain ^c   Tanguay, Simon ^b,c   Chevrette, Mario ^b,c   Aprikian, Armen ^b,c   Chevalier, Simone ^a,b,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Antisense RNA; Fer; Prostate cancer; Sex steroids; Tyrosine kinase

Indexed keywords

BETA CATENIN; CORTACTIN; FER PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; DOG; GROWTH REGULATION; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BASE SEQUENCE; CELL DIVISION; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; DOGS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033968740     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00205-1     Document Type: Article

References (40)

1. Allard P., Atfi A., Landry F., Chapdelaine A., Chevalier S. Estradiol activates p60src, p53/56lyn and renatured p50/55 protein tyrosine kinases in the dog prostate. Mol. Cell. Endocrinol. 126:1997;25-34.
2. Atfi A., Drobetsky E., Boissonneault M., Chapdelaine A., Chevalier S. Transforming growth factor beta down-regulates Src family protein tyrosine kinase signaling pathways. J. Biol. Chem. 269:1994;30688-30693.
3. Barrack E.R., Berry S.J. DNA synthesis in the canine prostate: effects of androgen and estrogen treatment. Prostate. 10:1987;45-56.
4. Ben-Dor I., Bern O., Tennenbaum T., Nir U. Cell cycle-dependent nuclear accumulation of the p94(fer) tyrosine kinase is regulated by its NH2 terminus and is affected by kinase domain integrity and ATP binding. Cell Growth Differ. 10:1999;113-129.
5. Black R.J., Bray F., Ferlay J., Parkin D.M. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur. J. Cancer. 33:1997;1075-1107.
6. Bonkhoff H. Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. Eur. Urol. 30:1996;201-205.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
8. Chevalier S., Bleau G., Roberts K.D., Chapdelaine A. Proliferation and differentiation of canine prostatic epithelial cells in culture. Mol. Cell. Endocrinol. 24:1981;198-208.
9. Chevalier S., Turcotte G., McKercher G., Boulanger P., Chapdelaine A. Steroid metabolism and binding in relation to prostatic cell growth and differentiation in vitro. Castagnetta L., d'Aquino S., Labrie F., Bradlow H.L. Steroid formation, degradation, and action in peripheral tissues. 595:1990;173-183 Annals of the New-York Academy of Sciences, New York.
10. De Marzo A.M., Meeker A.K., Epstein J.I., Coffey D.S. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am. J. Pathol. 153:1998;911-919.
11. Durocher Y., Chapdelaine A., Chevalier S. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145. Cancer Res. 49:1989;4818-4823.
12. Feldman R.A., Tam J.P., Hanafusa H. Antipeptide antiserum identifies a widely distributed cellular tyrosine kinase related to but distinct from the c-fps/fes-encoded protein. Mol. Cell. Endocrinol. 6:1986;1065-1073.
13. Fischer E.H. Protein phosphorylation and cellular regulation II. Angew. Chem. Int. Edit. 32:1993;1130-1137.
14. Gaudette L.A., Altmayer C.A., Wysocki M., Gao R.N. Cancer incidence and mortality across Canada. Health Rep. 10:1998;51-66.
15. Hanazono Y., Chiba S., Sasaki K., Mano H., Yazaki Y., Hirai H. Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. EMBO J. 12:1993;1641-1646.
16. Hao Q.L., Heisterkamp N., Groffen J. Isolation and sequence analysis of a novel human tyrosine kinase gene. Mol. Cell. Biol. 9:1989;1587-1593.
17. Hao Q.L., Ferris D.K., White G., Heisterkamp N., Groffen J. Nuclear and cytoplasmic location of the FER tyrosine kinase. Mol. Cell. Biol. 11:1991;1180-1184.
18. Heldin C.H. Protein tyrosine kinase receptors. Cancer Surv. 27:1996;7-24.
19. Keshet E., Itin A., Fischman K., Nir U. The testis-specific transcript (ferT) of the tyrosine kinase FER is expressed during spermatogenesis in a stage-specific manner. Mol. Cell. Endocrinol. 10:1990;5021-5025.
20. Kim L., Wong T.W. The cytoplasmic tyrosine kinase FER is associated with the catenin-like substrate pp120 and is activated by growth factors. Mol. Cell. Endocrinol. 15:1995;4553-4561.
21. Kim L., Wong T.W. Growth factor-dependent phosphorylation of the actin-binding protein cortactin is mediated by the cytoplasmic tyrosine kinase FER. J. Biol. Chem. 273:1998;23542-23548.
22. Landry F., Chapdelaine A., Bégin L.R., Chevalier S. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate. J. Urol. 155:1996;386-391.
23. Letwin K., Yee S.P., Pawson T. Novel protein-tyrosine kinase cDNAs related to fps/fes and eph cloned using anti-phosphotyrosine antibody. Oncogene. 3:1987;621-627.
24. MacDonald I., Levy J., Pawson T. Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein. Mol. Cell. Endocrinol. 5:1985;2543-2551.
25. Merk F.B., Ofner P., Kwan P.W.L., Leav I., Vena R.L. Ultrastructural and biochemical expressions of divergent differentiation in prostates of castrated dogs treated with estrogen and androgen. Lab. Invest. 47:1982;437-450.
26. Nguyen L.T., Beauregard G., Tessier S., Allard P., Atfi A., Durocher Y., Chapdelaine A., Potier M., Chevalier S. Radiation inactivation and in situ renaturation of protein tyrosine kinases reveal a major 50-kDa enzyme as part of a membrane complex present in dividing but not in resting prostatic epithelial cells. Biochem. Cell Biol. 74:1996;75-85.
27. Paulson R., Jackson J., Immergluck K., Bishop L.M. The DFer gene of Drosophila melanogaster encodes two membrane-associated proteins that can both transform vertebrate cells. Oncogene. 14:1997;641-652.
28. Pawson T., Letwin K., Lee T., Hao Q.L., Heisterkamp N., Groffen J. The FER gene is evolutionarily conserved and encodes a widely expressed member of the FPS/FES protein-tyrosine kinase family. Mol. Cell. Biol. 9:1989;5722-5725.
29. Quelle F.W., Sato N., Witthuhn B.A., Inhorn N.C., Eder M., Miyajima A., Griffin J.D., Ihle J.N. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14:1994;4335-4341.
30. Rizzino A. Soft agar growth assays for transforming growth factors and mitogenic peptides. Barnes D., Sirbasku D.A. Methods in Enzymology: Peptide Growth Factors. 146:1987;341-352 Academic Press, New York.
31. Rodrigues G.A., Park M. Oncogenic activation of tyrosine kinases. Curr. Biol. 4:1994;15-24.
32. Rosato R., Veltmaat J.M., Groffen J., Heisterkamp N. Involvement of the tyrosine kinase fer in cell adhesion. Mol. Cell. Endocrinol. 18:1998;5762-5770.
33. Sambrook, T., Fritsch, E., Maniatis, T. 1989. Molecular cloning: a laboratory manual. In: Nolan, C. (Ed.), Boston: Cold Spring Harbour Laboratory, pp. 9.22-9.23.
34. Schwartz Y., Ben-Dor I., Navon A., Motro B., Nir U. Tyrosine phosphorylation of the TATA element modulatory factor by the FER nuclear tyrosine kinases. FEBS Lett. 434:1998;339-345.
35. Storrie B., Madden A. Isolation of subcellular organelles. Deutscher M.P. Methods in Enzymology: Guide to Protein Purification. 182:1990;203-213 Academic Press, New York.
36. Tessier S., Chapdelaine A., Chevalier S. Alkali-resistant protein phosphorylation and tyrosine kinase activity of epithelial cell types from normal and metaplastic canine prostates. Mol. Cell. Endocrinol. 66:1989;59-70.
37. Tremblay L., Hauck W., Aprikian A.G., Bégin L.R., Chapdelaine A., Chevalier S. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int. J. Cancer. 68:1996a;164-171.
38. Tremblay L., Hauck W., Nguyen L.T., Allard P., Landry F., Chapdelaine A., Chevalier S. Regulation and activation of focal adhesion kinase and paxillin during the adhesion, proliferation, and differentiation of prostatic epithelial cells in vitro and in vivo. Mol. Endocrinol. 10:1996b;1010-1020.
39. Wang J.Y.J. Oncoprotein phosphorylation and cell cycle control. Biochim. Biophys. Acta. 1114:1992;179-192.
40. Witthuhn B.A., Quelle F.W., Silvennoinen O., Yi T., Tang B., Miura O., Ihle J.N. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 74:1993;227-236.